ArticleBMJ open2026
BRIGHT pathways: recommendations to improve the developmental follow-up of children with CHD in Canada - protocol for a nominal group study.
Article in BMJ open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionSystematic developmental follow-up for children with congenital heart disease (CHD) is essential for the timely detection of developmental delays and disorders and to put in place the supports and resources necessary to maximise function and support family well-being. Best practice guidelines recommend follow-up for children with CHD at high risk of developmental delays. However, many countries, including Canada, have faced barriers such as limitations in financial and human resources which have limited their ability to implement these important neurodevelopmental follow-up programmes. The aim of this project is to develop recommendations for evidence-based care pathways for the developmental follow-up of children and adolescents with CHD that are adapted to the Canadian health care context.
methodsThis study includes two steps: (1) a narrative review of current literature on the developmental follow-up of children with CHD and (2) a nominal group process involving patients, families, healthcare workers, researchers, policy-makers and government representatives that will be used to achieve consensus on practice recommendations. Purposive sampling will be used to select eligible participants so that all interested parties are well represented and reflective of a variety of experiences and opinions. Two to three groups of approximately 10 participants will be held via videoconferencing. The nominal groups will consist of a five-step process that will be repeated for each topic: (1) question; (2) idea generation; (3) discussion; (4) ranking; and (5) consensus. ANALYSIS: Data from the different groups will be merged. Ideas for which a consensus was reached (>80% agreement) during the meetings will be summarised. ETHICS AND DISSEMINATION: Ethical approval was obtained from The Hospital for Sick Children, Toronto, Canada (#1000081399) and McGill University, Montreal, Canada (#25-09-006). The findings of this study will be disseminated in peer-reviewed journals and conferences, presented at local, national and international conferences and disseminated to local, provincial and national governments to inform policy.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.